Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug stimulated prostacyclin release.

K U Weithmann

    La Ricerca in Clinica E in Laboratorio
    |January 1, 1981
    PubMed
    Summary

    Pentoxifylline (POF) enhances anti-aggregatory effects in vivo by boosting prostacyclin (PGI2)-like activity. This interaction requires intact vessel walls and platelets for POF

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.

    Journal of medicinal chemistry·1999
    Same author

    Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro.

    Free radical biology & medicine·1998
    Same author

    The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.

    Clinical chemistry and laboratory medicine·1998
    Same author

    Effects of tiaprofenic acid on urinary pyridinium crosslinks in adjuvant arthritic rats: comparison with doxycycline.

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]·1997
    Same author

    Effect of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation.

    Agents and actions·1994
    Same author

    Annexin proteins PP4 and PP4-X. Comparative characterization of biological activities of placental and recombinant proteins.

    The Biochemical journal·1990

    Area of Science:

    • Pharmacology
    • Cardiovascular Biology
    • Platelet Physiology

    Background:

    • Pentoxifylline (POF) is known to affect platelet aggregation.
    • Prostacyclin (PGI2) is a key regulator of platelet function and vascular tone.
    • The interaction between POF, PGI2, and platelet cyclic AMP (cAMP) requires further elucidation.

    Purpose of the Study:

    • To investigate the in vivo mechanism of pentoxifylline's anti-aggregatory effect.
    • To determine the role of prostacyclin (PGI2) and vessel wall interactions in POF's action.
    • To examine the impact of POF on platelet cAMP levels in conjunction with PGI2.

    Main Methods:

    • In vivo and in vitro experiments were conducted to assess platelet aggregation.
    • Measurements of cyclic AMP (cAMP) levels in human platelets were performed.
    • The effects of pentoxifylline (POF) alone and in combination with prostacyclin (PGI2) were evaluated.

    Main Results:

    • Pentoxifylline (POF) demonstrated an in vivo anti-aggregatory effect, potentially mediated by enhanced prostacyclin (PGI2)-like activity from vessel walls.
    • POF alone had minimal in vitro effect on platelet cAMP levels or aggregation inhibition without PGI2.
    • Combined POF and PGI2 significantly increased cAMP levels and inhibited aggregation in vitro, exceeding the effects of PGI2 alone.

    Conclusions:

    • The anti-aggregatory action of pentoxifylline (POF) in vivo is dependent on the interaction between intact vessel walls and platelets.
    • Enhanced prostacyclin (PGI2)-like activity and subsequent stimulation of platelet adenylate cyclase are crucial for POF's in vivo effects.
    • POF potentiates the effects of PGI2 on platelet cAMP levels and aggregation inhibition, highlighting a synergistic relationship.

    Related Experiment Videos